Qiagen NV
QGEN47.450USD
+0.220+0.47%
終値 06/25, 16:00（ET）15分遅れの株価
10.28B時価総額
122.93直近12ヶ月PER
詳細情報 Qiagen NV 企業名
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
企業情報
企業コードQGEN
会社名Qiagen NV
上場日Sep 01, 1996
設立日1996
最高経営責任者「CEO」Mr. Thierry Bernard
従業員数5765
証券種類Ordinary Share
決算期末Sep 01
本社所在地Hulsterweg 82
都市VENLO
証券取引所NYSE Consolidated
国Netherlands
郵便番号5912 PL
電話番号31773556600
ウェブサイトhttps://www.qiagen.com/
企業コードQGEN
上場日Sep 01, 1996
設立日1996
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
383.09K
+59.93%
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
312.13K
+75.76%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
171.79K
-57.00%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
47.22K
+10.37%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
16.27K
+30.83%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.97K
--
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
24.00
--
Ms. Eva van Pelt
Ms. Eva van Pelt
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Toralf Haag, Ph.D.
Dr. Toralf Haag, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Lawrence A. Rosen
Mr. Lawrence A. Rosen
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
383.09K
+59.93%
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
312.13K
+75.76%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
171.79K
-57.00%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
47.22K
+10.37%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
16.27K
+30.83%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.97K
--
収益内訳
通貨: USD更新時刻: Sun, Apr 6
通貨: USD更新時刻: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
事業別USD
会社名
収益
比率
Consumables and Related Revenues
1.76B
88.98%
Instrumentation
218.00M
11.02%
地域別USD
会社名
収益
比率
United States
942.01M
47.62%
Europe & Middle East & Africa
648.49M
32.78%
Asia, Pacific & Rest of the World
298.15M
15.07%
Other Americas
89.56M
4.53%
事業別
地域別
事業別USD
会社名
収益
比率
Consumables and Related Revenues
1.76B
88.98%
Instrumentation
218.00M
11.02%
株主
更新時刻: Sat, Jun 14
更新時刻: Sat, Jun 14
株主統計
種類
株主統計
株主統計
比率
Wellington Management Company, LLP
11.29%
MFS Investment Management
11.20%
BlackRock Institutional Trust Company, N.A.
9.31%
The Vanguard Group, Inc.
4.06%
Amundi Asset Management, SAS
1.94%
Other
62.21%
株主統計
株主統計
比率
Wellington Management Company, LLP
11.29%
MFS Investment Management
11.20%
BlackRock Institutional Trust Company, N.A.
9.31%
The Vanguard Group, Inc.
4.06%
Amundi Asset Management, SAS
1.94%
Other
62.21%
種類
株主統計
比率
Investment Advisor/Hedge Fund
46.01%
Investment Advisor
30.03%
Hedge Fund
3.22%
Research Firm
3.21%
Sovereign Wealth Fund
1.87%
Holding Company
1.17%
Pension Fund
1.10%
Bank and Trust
1.07%
Individual Investor
0.44%
Other
11.89%
機関投資家保有株
更新時刻: Mon, Jan 20
更新時刻: Mon, Jan 20
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q1
987
158.50M
73.34%
-14.17M
2024Q4
1010
129.03M
59.70%
-70.06M
2024Q3
1010
183.22M
84.72%
-23.62M
2024Q2
1002
184.34M
84.75%
+8.40M
2024Q1
988
165.20M
76.61%
-7.18M
2023Q4
993
165.11M
76.72%
-10.52M
2023Q3
987
159.93M
74.32%
-12.21M
2023Q2
996
162.43M
75.49%
-6.05M
2023Q1
1001
160.07M
74.44%
-9.45M
2022Q4
1009
160.10M
74.55%
-10.38M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Wellington Management Company, LLP
23.29M
10.78%
+2.11M
+9.98%
Jan 31, 2025
BlackRock Institutional Trust Company, N.A.
19.32M
8.94%
-13.86K
-0.07%
Mar 04, 2025
The Vanguard Group, Inc.
8.54M
3.95%
+77.90K
+0.92%
Dec 31, 2024
Amundi Asset Management, SAS
4.71M
2.18%
-798.61K
-14.50%
Dec 31, 2024
Norges Bank Investment Management (NBIM)
3.96M
1.83%
-111.67K
-2.74%
Dec 31, 2024
DWS Investments UK Limited
2.14M
0.99%
+712.11K
+50.02%
Dec 31, 2024
Swedbank Robur Fonder AB
2.03M
0.94%
-95.44K
-4.49%
Feb 28, 2025
詳細を見る
関連ETF
更新時刻: Fri, Jun 6
更新時刻: Fri, Jun 6
銘柄名
比率
First Trust Nasdaq Lux Digi Health Solutions ETF
4.69%
Global X Genomics & Biotechnology ETF
3.96%
Invesco Biotechnology & Genome ETF
3.29%
ROBO Global Healthcare Technology & Innovation ETF
1.8%
Franklin Genomic Advancements ETF
1.75%
VanEck Biotech ETF
1.74%
iShares Health Innovation Active ETF
1.02%
Harbor Long-Short Equity ETF
0.9%
FlexShares US Quality Low Volatility Index Fund
0.85%
WisdomTree US AI Enhanced Value Fund
0.79%
詳細を見る
First Trust Nasdaq Lux Digi Health Solutions ETF
比率4.69%
Global X Genomics & Biotechnology ETF
比率3.96%
Invesco Biotechnology & Genome ETF
比率3.29%
ROBO Global Healthcare Technology & Innovation ETF
比率1.8%
Franklin Genomic Advancements ETF
比率1.75%
VanEck Biotech ETF
比率1.74%
iShares Health Innovation Active ETF
比率1.02%
Harbor Long-Short Equity ETF
比率0.9%
FlexShares US Quality Low Volatility Index Fund
比率0.85%
WisdomTree US AI Enhanced Value Fund
比率0.79%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 18, 2024
Merger
25<24.25
Jan 18, 2024
Merger
25<24.25
日付
種類
比率
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 18, 2024
Merger
25<24.25
Jan 18, 2024
Merger
25<24.25
Jan 18, 2024
Merger
25<24.25
Jan 18, 2024
Merger
25<24.25
